Vertex Pharmaceuticals

Vertex is a global biotechnology company headquartered in Boston that develops transformative medicines for serious diseases through scientific innovation. Its flagship programs target cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, while a robust pipeline explores APOL1-mediated kidney disease, IgA nephropathy, type 1 diabetes, and other conditions. Vertex leverages deep insights into causal human biology across multiple modalities to accelerate clinical and research programs worldwide. The company is consistently recognized as a top workplace and has received prestigious awards such as the Prix Galien and the Breakthrough Prize, underscoring its impact and culture of excellence. Vertex's commitment to innovation, patient-centric research, and a collaborative global footprint makes it a leader in the biotechnology industry.